Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 5, 2006, Pages 347-355

  Rysz, Jacek ^a   Potargowicz, Elzbieta ^a   Banach, Maciej ^a   Łuczyńska, Maria ^a   Stolarek, Robert ^a   Białasiewicz, Piotr ^a   Kasielski, Marek ^a   Ciałkowska Rysz, Aleksandra ^a   Nowak, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hemodialysis; Reactive oxygen species; Uremia; Whole blood chemiluminescence

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL MALEATE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FUROSEMIDE; METOPROLOL; REACTIVE OXYGEN METABOLITE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; MALE; PHAGOCYTE; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LUMINESCENCE; LUMINOL; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PHAGOCYTES; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; UREMIA;

EID: 33750333858     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0040-0     Document Type: Article

References (51)

1. Ahmed A., Krol E., Smogorzewski M. and Massry S. G. (1999): Effect of amlodipine therapy on the monoclonal antibody 3G8-induced calcium signal in polymorphonuclear leukocytes of hemodialysis patients. Am. J. Nephrol., 19, 505-508.
2. Alexiewicz J. M., Smogorzewski M., Fadda G. Z. and Massry S. G. (1991): Impaired phagocytosis in dialysis patients: studies on mechanisms. Am. J. Nephrol., 11, 102-111.
3. Bialasiewicz P., Wlodarczyk A., Dudkiewicz B. and Nowak D. (2004): Inhibitory effect of furosemide on activation of human peripheral blood polymorphonuclear leukocytes stimulated with n-formyl-methionyl-leucyl- phenylalanine. Int. Immunopharmacol., 4, 819-831.
4. Bonomini M., Stuard S., Carreno M. P., Settefrati N., Santarelli P., Haeffner-Cavaillon N. and Albertazzi A. (1997): Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Nephron, 75, 402-411.
5. Chen MF, Chang CL, Liou SY (1998): Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif., 16, 290-300.
6. Clapperton M., Beswick P. H., Abdullah I., Dargie H. J., Fisher A. C. and McMurray J. (1995): Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils. Br. J. Clin. Pharmacol., 40, 31-35.
7. Cohen M. S., Elliott D. M., Chaplinski T., Pike M. M. and Niedel J. E. (1982): A defect in the oxidative metabolism of human polymorphonuclear leukocytes that remain in circulation early in hemodialysis. Blood, 60, 1283-1289.
8. Descamps-Latscha B., Goldfarb B., Nguyen A. T., Landais P., London G., Haeffner-Cavaillon N., Jacquot C., Herbelin A. and Kazatchkine M. (1991): Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. Nephron, 59, 279-285.
9. Deutsch A., Chaimovitzch C., Nagauker-Shriker O., Zlotnik M., Shany S. and Levy R. P. (1995): Elevated superoxide generation in mononuclear phagocytes by treatment with 1 alpha hydroxyvitamin D3: changes in kinetics and in oxidase cytosolic factor p47. J. Am. Soc. Nephrol., 6, 102-109.
10. Drueke T., Witko-Sarsat V., Massy Z., Descamps-Latscha B., Guerin A. P., Marchais S. J., Gausson V. and London G. M. (2002): Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation, 106, 2212-2217.
11. Dunzendorfer S. and Wiedermann C. J. (2000): Modulation of neutrophil migration and superoxide anion release by metoprolol. J. Mol. Cell. Cardiol., 32, 915-924.
12. Dursun E., Ozben T., Suleymanlar G., Dursun B. and Yakupoglu G. (2002): Effect of hemodialysis on the oxidative stress and antioxidants. Clin. Chem. Lab. Med., 40, 1009-1013.
13. Eckardt K. U., Eckardt H., Harber M. J. and Asscher A. W. (1986): Analysis of polymorphonuclear leukocyte respiratory burst activity in uremic patients using whole-blood chemiluminescence. Nephron, 43, 274-278.
14. Gastaldello K., Husson C., Wens R., Vanherweghem J. L. and Tielemans C. (2000): Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. Nephrol. Dial. Transplant., 15, 1638-1646.
15. Glorieux G., Helling R., Henle T., Brunet P., Deppisch R., Lameire N. and Vanholder R. (2004): In vitro evidence for immune activating effect of specific AGE structures retained in uremia. Kidney Int., 66, 1873-1880.
16. Hauser C. J., Desai N., Fekete Z., Livingston D. H. and Deitch E. A. (1999): Priming of neutrophil [Ca2+]i signaling and oxidative burst by human fracture fluids. J. Trauma, 47, 854-858.
17. Himmelfarb J., Lazarus J. M. and Hakim R. (1991): Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am. J. Kidney Dis., 17, 271-276.
18. Hoffmann U., Fischereder M., Marx M., Schweda F., Lang B., Straub R. H. and Kramer B. K. (2003): Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material? Am. J. Nephrol., 23, 442-447.
19. Hornych A., Remy P., Luong N., Aumont J. and Bariety J. (1996): Biocompatibility of haemodialysis membranes: haemodialysis-related leukotriene B4 and C4 generation. Nephron, 74, 11-18.
20. Huraib S., Abu-Aisha H., al-Momen A., al-Wakeel J., Memon N. and al-Tuwaijri A. (1997): Effect of recombinant human erythropoietin on lymphocyte phenotyping and phagocyte activity in hemodialysis patients. Am. J. Kidney Dis., 29, 866-870.
21. Ikizler T. A., Morrow J. D., Roberts L. J., Evanson J. A., Becker B., Hakim R. M., Shyr Y. and Himmelfarb J. (2002): Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin. Nephrol., 58, 190-197.
22. Klein J. B., McLeish K. R. and Ward R. A. (1999): Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst. Am. J. Kidney Dis., 33, 483-491.
23. Kopprasch S., Graessler J., Kohl M., Bergmann S. and Schröder H. E. (1996): Comparison of circulating phagocyte oxidative activity measured by chemiluminescence in whole blood and isolated polymorphonuclear leukocytes. Clin. Chim. Acta, 253, 145-157.
24. Kukovetz E. M., Bratschitsch G., Hofer H. P., Egger G. and Schaur R. J. (1997): Influence of age on the release of reactive oxygen species by phagocytes as measured by a whole blood chemiluminescence assay. Free Radic. Biol. Med., 22, 433-438.
25. Lewis S. L., Van Epps D. E. and Chenoweth D. E. (1987): Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients. Blood Purif., 5, 138-154.
26. Lim P. S., Cheng Y. M. and Wei Y. H. (2002): Increase in oxidative damage to lipids and proteins in skeletal muscle of uremic patients. Free Radic. Res., 36, 295-301.
27. Loughrey C. M., Young I. S., Lightbody J. H., McMaster D., McNamee P. T. and Trimble E. R. (1994): Oxidative stress in hemodialysis. QJM, 87, 679-683.
28. Luciak M. and Trznadel K. (1997): Free oxygen species metabolism during hemodialysis with different membranes. Nephrol. Dial. Transplant., 6 (suppl. 3), 66-70.
29. Mariano F., Tetta C., Guida G., Triolo G. and Camussi G. (2001): Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int., 60, 1598-1605.
30. Massry S. G., Schaefer R. M., Teschner M., Roeder M., Zull J. F. and Heidland A. (1989): Effect of parathyroid hormone on elastase release from human polymorphonuclear leucocytes. Kidney Int., 36, 883-890.
31. Mezzano D., Pais E. O., Aranda E., Panes O., Downey P., Ortiz M., Tagle R., Gonzalez F., Quiroga T., Caceres M. S., Leighton F. and Pereira J. (2001): Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int., 60, 1844-1850.
32. Morikawa K. (1989): Evaluation of leukocyte oxidative metabolism using whole blood samples by chemiluminescence and flow cytometric assays. Rinsho Byori, 37, 1013-1019.
33. Nguyen A. T., Lethias C., Zingraff J., Herbelin A., Naret C., Descamps-Latscha B. (1985): Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int., 28, 158-167.
34. Porter C. J., Burden R. P., Morgan A. G., Daniels I. and Fletcher J. (1997): Impaired bacterial killing and hydrogen peroxide production by polymorphonuclear neutrophils in end-stage renal failure. Nephron, 77, 479-481.
35. Rebecchi I. M., Ferreira Novo N., Julian Y. and Campa A. (2000): Oxidative metabolism and release of myeloperoxidase from polymorphonuclear leukocytes obtained from blood sedimentation in a Ficoll-Hypaque gradient. Cell Biochem. Funct., 18, 127-132.
36. Rysz J., Bartnicki P. and Stolarek R. A. (2005): Erythropoietin therapy in chronic renal failure patients prior to hemodialysis. Arch. Med. Sci., 1, 55-58.
37. Rysz J., Kasielski M., Apanasiewicz J., Krol M., Woznicki A., Luciak M. and Nowak D. (2004): Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis. Nephrol. Dial. Transplant., 19, 158-163.
38. Sharma A., Tripathi A. K., Kalra O. P. and Chakrabarty A. K. (2000): Impaired function of neutrophils in uraemic patients. Natl. Med. J. India, 13, 121-124.
39. Stock J. L., Coderre J. A. and Levine P. H. (1982): Effects of calcium-regulating hormones and drugs on human monocyte chemiluminescence. J. Clin. Endocrinol. Metab., 55, 956-960.
40. Szkudlarek U., Luczynska M., Kasielski M., Kaucka S. and Nowak D. (2003): Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Respir. Med., 97, 718-725.
41. Tarakcioglu M., Erbagci A. B., Usalan C., Deveci R. and Kocabas R. (2003): Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Mediators Inflamm., 12, 15-19.
42. Todeschini M., Macconi D., Fernandez N. G., Ghilardi M., Anabaya A., Binda E., Morigi M., Cattaneo D., Perticucci E., Remuzzi G. and Noris M. (2002): Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophilactivation. Am. J. Kidney Dis., 40, 783-793.
43. Tsuruoka S., Kawaguchi A., Nishiki K., Hayasaka T., Fukushima C., Sugimoto K., Saito T. and Fujimura A. (2002): Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am. J. Kidney Dis., 39, 127-133.
44. Ueda Y. (1989): Production of oxygen free radicals by phagocytes in patients on hemodialysis. Kansenshogaku Zasshi, 63, 997-1006.
45. Ward R. A. and McLeish K. R. (1995): Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J. Am. Soc. Nephrol., 5, 1697-1702.
46. Ward R. A. and McLeish K. R. (1995): Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif. Organs, 19, 801-807.
47. Watson F., Robinson J. J. and Edwards S. W. (1992): Neutrophil function in whole blood and after purification: changes in receptor expression, oxidase activity and responsiveness to cytokines. Biosci. Rep., 12, 123-133.
48. Wong R. K., Pettit A. I., Quinn P. A., Jennings S. C., Davies J. E. and Ng L. L. (2003): Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation, 108, 1858-1864.
49. Wysocki H., Siminiak T., Zozulinska D. and Wierusz-Wysocka B. (1995): Evaluation of the effect of oral enalapril on neutrophil functions: comparison with the in vitro effect of enalapril and enalaprilat. Pol. J. Pharmacol., 47, 53-58.
50. Vanholder R., De Smet R., Waterloos M. A., Van Landschoot N., Vogeleere P., Hoste E. and Ringoir S. (1995): Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int., 47, 510-517.
51. Veys N., Vanholder R. and Ringoir S. (1992): Correction of deficient phagocytosis during erythropoietin treatment in maintenance hemodialysis patients. Am. J. Kidney Dis., 19, 358-363.